Laboratory Medicine ›› 2015, Vol. 30 ›› Issue (5): 427-432.DOI: 10.3969/j.issn.1673-8640.2015.05.005
Previous Articles Next Articles
ZHOU Yafei, WANG Yueting, YU Jiaping
Received:
2014-12-12
Online:
2015-05-30
Published:
2015-06-17
CLC Number:
ZHOU Yafei, WANG Yueting, YU Jiaping. Research on the determination of serum steroid hormones by isotope dilution HPLC-MS/MS[J]. Laboratory Medicine, 2015, 30(5): 427-432.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2015.05.005
类固醇激素 | 内标物 | 保留时间(min) | MRM监测离子对(Q1/Q3) | DP | CE | CXP |
---|---|---|---|---|---|---|
DHEA | d6-DHEA | 4.73 | 304.1/253.2 | 95 | 24 | 15 |
17α-OHP4 | d8-17OHP4 | 4.92 | 361.1/112.2 | 145 | 45 | 10 |
17-OHP5 | d8-17OHP4 | 4.54 | 348.1/330.3 | 60 | 14 | 8 |
E1 | d2-E1 | 4.42 | 286.1/253.0 | 75 | 22 | 10 |
CORT | d9-P4 | 4.49 | 410.0/377.2 | 80 | 25 | 9 |
AD | d3-T | 4.85 | 317.1/112.2 | 130 | 41 | 6 |
P5 | d9-P4 | 5.87 | 332.1/86.2 | 110 | 41 | 4 |
DHT | d3-T | 5.24 | 306.2/81.1 | 127 | 53 | 15 |
类固醇激素 | 内标物 | 保留时间(min) | MRM监测离子对(Q1/Q3) | DP | CE | CXP |
---|---|---|---|---|---|---|
DHEA | d6-DHEA | 4.73 | 304.1/253.2 | 95 | 24 | 15 |
17α-OHP4 | d8-17OHP4 | 4.92 | 361.1/112.2 | 145 | 45 | 10 |
17-OHP5 | d8-17OHP4 | 4.54 | 348.1/330.3 | 60 | 14 | 8 |
E1 | d2-E1 | 4.42 | 286.1/253.0 | 75 | 22 | 10 |
CORT | d9-P4 | 4.49 | 410.0/377.2 | 80 | 25 | 9 |
AD | d3-T | 4.85 | 317.1/112.2 | 130 | 41 | 6 |
P5 | d9-P4 | 5.87 | 332.1/86.2 | 110 | 41 | 4 |
DHT | d3-T | 5.24 | 306.2/81.1 | 127 | 53 | 15 |
分析物 | 曲线浓度 (ng/mL) | 斜率 | r值 | LLOQ | |||
---|---|---|---|---|---|---|---|
S/N | CV(%) | 准确度(%) | |||||
DHEA | 0.125~40 | 0.423 | 0.999 5 | 0.125 0 | 14.0 | 4.6 | 119.0 |
17α-OHP4 | 0.125~10 | 0.226 | 0.999 0 | 0.125 0 | 10.5 | 5.8 | 97.4 |
AD | 0.0625~10 | 0.351 | 0.999 6 | 0.062 5 | 10.0 | 6.1 | 110.0 |
P5 | 0.0313~10 | 0.275 | 0.999 3 | 0.031 3 | 10.5 | 9.2 | 88.0 |
17-OHP5 | 0.078~25 | 1.570 | 0.999 2 | 0.078 0 | 10.7 | 12.7 | 97.2 |
DHT | 0.125~2 | 0.034 | 0.998 8 | 0.250 0 | 24.5 | 6.3 | 130.0 |
CORT | 0.625~50 | 0.443 | 0.999 0 | 0.625 0 | 11.0 | 5.7 | 132.0 |
E1 | 0.05~2 | 0.052 | 0.998 0 | 0.031 3 | 10.0 | 13.5 | 137.0 |
分析物 | 曲线浓度 (ng/mL) | 斜率 | r值 | LLOQ | |||
---|---|---|---|---|---|---|---|
S/N | CV(%) | 准确度(%) | |||||
DHEA | 0.125~40 | 0.423 | 0.999 5 | 0.125 0 | 14.0 | 4.6 | 119.0 |
17α-OHP4 | 0.125~10 | 0.226 | 0.999 0 | 0.125 0 | 10.5 | 5.8 | 97.4 |
AD | 0.0625~10 | 0.351 | 0.999 6 | 0.062 5 | 10.0 | 6.1 | 110.0 |
P5 | 0.0313~10 | 0.275 | 0.999 3 | 0.031 3 | 10.5 | 9.2 | 88.0 |
17-OHP5 | 0.078~25 | 1.570 | 0.999 2 | 0.078 0 | 10.7 | 12.7 | 97.2 |
DHT | 0.125~2 | 0.034 | 0.998 8 | 0.250 0 | 24.5 | 6.3 | 130.0 |
CORT | 0.625~50 | 0.443 | 0.999 0 | 0.625 0 | 11.0 | 5.7 | 132.0 |
E1 | 0.05~2 | 0.052 | 0.998 0 | 0.031 3 | 10.0 | 13.5 | 137.0 |
分析物 | 批内 | 批间 | ||||
---|---|---|---|---|---|---|
s(ng/mL) | CV(%) | s(ng/mL) | CV(%) | |||
DHEA | 2.012 | 0.083 | 4.13 | 2.083 | 0.102 | 4.90 |
17α-OHP4 | 0.928 | 0.051 | 5.50 | 1.023 | 0.069 | 6.74 |
AD | 0.675 | 0.013 | 1.93 | 0.631 | 0.048 | 7.61 |
P5 | 0.593 | 0.044 | 7.42 | 0.608 | 0.080 | 13.16 |
17-OHP5 | 2.702 | 0.138 | 5.11 | 2.793 | 0.304 | 10.88 |
CORT | 6.777 | 0.488 | 7.20 | 6.673 | 0.696 | 10.43 |
DHT | 0.387 | 0.036 | 9.30 | 0.316 | 0.039 | 12.34 |
E1 | 0.036 2 | 0.005 | 13.81 | 0.027 2 | 0.004 4 | 16.18 |
分析物 | 批内 | 批间 | ||||
---|---|---|---|---|---|---|
s(ng/mL) | CV(%) | s(ng/mL) | CV(%) | |||
DHEA | 2.012 | 0.083 | 4.13 | 2.083 | 0.102 | 4.90 |
17α-OHP4 | 0.928 | 0.051 | 5.50 | 1.023 | 0.069 | 6.74 |
AD | 0.675 | 0.013 | 1.93 | 0.631 | 0.048 | 7.61 |
P5 | 0.593 | 0.044 | 7.42 | 0.608 | 0.080 | 13.16 |
17-OHP5 | 2.702 | 0.138 | 5.11 | 2.793 | 0.304 | 10.88 |
CORT | 6.777 | 0.488 | 7.20 | 6.673 | 0.696 | 10.43 |
DHT | 0.387 | 0.036 | 9.30 | 0.316 | 0.039 | 12.34 |
E1 | 0.036 2 | 0.005 | 13.81 | 0.027 2 | 0.004 4 | 16.18 |
分析物 | 加标量 (ng/mL) | 测定值 (ng/mL) | RSD | 加标回收率 (%) |
---|---|---|---|---|
DHEA | 0 | 6.0±0.2 | 3.8 | — |
1.0 | 7.2±0.3 | 4.9 | 120.0 | |
5.0 | 10.4±0.3 | 2.8 | 88.0 | |
50.0 | 55.5±1.1 | 2.0 | 99.0 | |
17α-OHP4 | 0 | 1.7±0.2 | 10.1 | — |
0.5 | 2.1±0.02 | 1.1 | 80.0 | |
1.0 | 2.9±0.2 | 6.7 | 120.0 | |
10.0 | 14.0±1.2 | 8.2 | 123.0 | |
AD | 0 | 1.8±0.1 | 4.7 | — |
0.5 | 2.3±0.1 | 4.2 | 100.0 | |
1.0 | 3.0±0.06 | 1.8 | 120.0 | |
10.0 | 14.0±0.44 | 3.1 | 122.0 | |
P5 | 0 | 0.86±0.06 | 6.6 | — |
0.5 | 1.5±0.02 | 1.4 | 128.0 | |
1.0 | 2.1±0.04 | 1.7 | 124.0 | |
10.0 | 10.6±0.2 | 1.9 | 97.0 | |
17-OHP5 | 0 | 3.8±0.16 | 4.2 | — |
0.5 | 4.2±0.16 | 3.8 | 80.0 | |
1.0 | 5.0±0.1 | 2.6 | 120.0 | |
10.0 | 14.3±0.2 | 1.5 | 105.0 | |
CORT | 0 | 2.2±0.04 | 1.8 | — |
0.5 | 2.6±0.04 | 0.6 | 80.0 | |
1.0 | 3.2±0.1 | 3.3 | 100.0 | |
10.0 | 12.6±0.2 | 1.7 | 104.0 | |
DHT | 0 | 0.35±0.02 | 9.1 | — |
0.5 | 0.84±0.08 | 4.3 | 98.0 | |
1.0 | 1.43±0.1 | 7.0 | 108.0 | |
10.0 | 11.1±0.3 | 2.9 | 108.0 | |
E1 | 0 | 0.04±0.005 | 12.7 | — |
0.5 | 0.47±0.05 | 10.2 | 86.0 | |
1.0 | 1.23±0.06 | 4.8 | 119.0 | |
10.0 | 13.1±0.17 | 1.3 | 130.6 |
分析物 | 加标量 (ng/mL) | 测定值 (ng/mL) | RSD | 加标回收率 (%) |
---|---|---|---|---|
DHEA | 0 | 6.0±0.2 | 3.8 | — |
1.0 | 7.2±0.3 | 4.9 | 120.0 | |
5.0 | 10.4±0.3 | 2.8 | 88.0 | |
50.0 | 55.5±1.1 | 2.0 | 99.0 | |
17α-OHP4 | 0 | 1.7±0.2 | 10.1 | — |
0.5 | 2.1±0.02 | 1.1 | 80.0 | |
1.0 | 2.9±0.2 | 6.7 | 120.0 | |
10.0 | 14.0±1.2 | 8.2 | 123.0 | |
AD | 0 | 1.8±0.1 | 4.7 | — |
0.5 | 2.3±0.1 | 4.2 | 100.0 | |
1.0 | 3.0±0.06 | 1.8 | 120.0 | |
10.0 | 14.0±0.44 | 3.1 | 122.0 | |
P5 | 0 | 0.86±0.06 | 6.6 | — |
0.5 | 1.5±0.02 | 1.4 | 128.0 | |
1.0 | 2.1±0.04 | 1.7 | 124.0 | |
10.0 | 10.6±0.2 | 1.9 | 97.0 | |
17-OHP5 | 0 | 3.8±0.16 | 4.2 | — |
0.5 | 4.2±0.16 | 3.8 | 80.0 | |
1.0 | 5.0±0.1 | 2.6 | 120.0 | |
10.0 | 14.3±0.2 | 1.5 | 105.0 | |
CORT | 0 | 2.2±0.04 | 1.8 | — |
0.5 | 2.6±0.04 | 0.6 | 80.0 | |
1.0 | 3.2±0.1 | 3.3 | 100.0 | |
10.0 | 12.6±0.2 | 1.7 | 104.0 | |
DHT | 0 | 0.35±0.02 | 9.1 | — |
0.5 | 0.84±0.08 | 4.3 | 98.0 | |
1.0 | 1.43±0.1 | 7.0 | 108.0 | |
10.0 | 11.1±0.3 | 2.9 | 108.0 | |
E1 | 0 | 0.04±0.005 | 12.7 | — |
0.5 | 0.47±0.05 | 10.2 | 86.0 | |
1.0 | 1.23±0.06 | 4.8 | 119.0 | |
10.0 | 13.1±0.17 | 1.3 | 130.6 |
[1] | KOAL T,SCHMIEDERER D,PHAM-TUAN H,et al.Standardized LC-MS/MS based steroid hormone profile-analysis[J]. J Steroid Biochem Mol Biol,2012,129(3-5): 129-138. |
[2] | ELIASSEN AH,SPIEGELMAN D,XU X,et al.Urinary estrogens and estrogen metabolites and subsequent risk of breast cancer among premenopausal women[J]. Cancer Res,2012,72(3): 696-706. |
[3] | RIFFLE BW,HENDERSON WM,LAWS SC.Measurement of steroids in rats after exposure to an endocrine disruptor: mass spectrometry and radioimmunoassay demonstrate similar results[J]. J Pharmacol Toxicol Methods,2013,68(3): 314-322. |
[4] | XIN TB,CHEN H,LIN Z,et al.A secondary antibody format chemiluminescence immunoassay for the determination of estradiol in human serum[J]. Talanta,2010,82(4): 1472-1477. |
[5] | HANSEN M,JACOBSEN NW,NIELSEN FK,et al.Determination of steroid hormones in blood by GC-MS/MS[J]. Anal Bioanal Chem,2011,400(10): 3409-3417. |
[6] | KEEVIL BG,MACDONALD P,MACDOWALL W,et al.Salivary testosterone measurement by liquid chromatography tandem mass spectrometry in adult males and females[J]. Ann Clin Biochem,2014,51(Pt 3): 368-378. |
[7] | KETHA H,KAUR S,GREBE SK,et al.Clinical applications of LC-MS sex steroid assays: evolution of methodologies in the 21st century[J]. Curr Opin Endocrinol Diabetes Obes,2014,21(3): 217-226. |
[8] | FANELLI F,BELLUOMO I,DI LALLO VD,et al.Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults[J]. Steroids,2011,76(3): 244-253. |
[9] | 宋云霄,欧美贤,李水军,等. 同位素稀释质谱法、酶法和碱性苦味酸法测定血清肌酐方法比较[J]. 检验医学,2013,28(8): 698-703. |
[10] | LI X,HU B,DING J,et al.Rapid characterization of complex viscous samples at molecular levels by neutral desorption extractive electrospray ionization mass spectrometry[J]. Nat Protoc,2011,6(7): 1010-1025. |
[11] | ZHAN S,SHAO Q,FAN X,et al.Development of a sensitive LC-MS/MS method for simultaneous quantification of eleven constituents in rat serum and its application to a pharmacokinetic study of a Chinese medicine Shengmai injection[J]. Biomed Chromatogr,2015,29(2): 275-284. |
[12] | DÉGLON J,THOMAS A,DAALI Y,et al. Automated system for on-line desorption of dried blood spots applied to LC/MS/MS pharmacokinetic study of flurbiprofen and its metabolite[J]. J Pharm Biomed Anal,2011,54(2): 359-367. |
[13] | JUNG S,TRAN NT,GOSPE SM JR,et al.Preliminary investigation of the use of newborn dried blood spots for screening pyridoxine-dependent epilepsy by LC-MS/MS[J]. Mol Genet Metab,2013,110(3): 237-240. |
[14] | SAITO K,NOMURA F.Mass spectrometry application for clinical diagnostics chairmen's introductory remarks[J]. Rinsho Byori,2013,61(9): 803-804. |
[15] | 韩连书,高晓岚,叶军,等. 串联质谱检测干血滤纸片氨基酸方法的建立[J]. 检验医学,2005,20(3): 220-223. |
[16] | MAURER HH.Advances in analytical toxicology: the current role of liquid chromatography-mass spectrometry in drug quantification in blood and oral fluid[J]. Anal Bioanal Chem,2005,381(1): 110-118. |
[17] | MAURER HH.Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology[J]. Anal Bioanal Chem,2007,388(7): 1315-1325. |
[18] | REGAL P,VÁZQUEZ BI,FRANCO CM,et al. Quantitative LC-MS/MS method for the sensitive and simultaneous determination of natural hormones in bovine serum[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2009,877(24): 2457-2464. |
[1] | LI Xijiu, ZHOU Jianwei, ZHANG Qin, LONG Yunlin, WU Yingsong. Establishment and performance evaluation of UPLC-MS/MS for 6 markers in dried blood spots [J]. Laboratory Medicine, 2023, 38(5): 446-453. |
[2] | XU Weixin, CHEN Qing, DU Wenyong, GAO Yan. Plasma metabolic markers in patients with insomnia disorder [J]. Laboratory Medicine, 2023, 38(5): 454-459. |
[3] | WU Jie, LI Zenghe, CHEN Baorong, KONG Xujing. Establishment of traceable steroid hormone standard curve for dried blood spot samples [J]. Laboratory Medicine, 2023, 38(5): 489-493. |
[4] | Expert Group on the Consensus on Androgen Testing in Polycystic Ovary Syndrome China Association for Promotion of Health Science and Technology-Fertility Protection and Preservation Committee. Consensus on androgen testing in polycystic ovary syndrome [J]. Laboratory Medicine, 2023, 38(3): 203-208. |
[5] | YANG Xiaodong, LI Quanle, PAN Qingqing, ZHOU Jing, XIE Yangmin, ZOU Jihua, SHEN Min, ZHANG Man. Establishment and performance evaluation of candidate reference measurement procedure for the determination of immunosuppressive drugs in human whole blood by ID-LC-MS/MS [J]. Laboratory Medicine, 2023, 38(3): 215-222. |
[6] | WANG Yajie, ZU Bailing, GAN Chenxin, WU Jiaoxiang, SHU Jie, HANG Chen, CHEN Minghui, LIN Fujun, HU Zhigang, HUANG Biao, SHENG Huiming. Identification of plasma differential peptids in PLA2R1-related membranous nephropathy patients [J]. Laboratory Medicine, 2023, 38(3): 223-229. |
[7] | HUANG Yuan, CHEN Feng, MAO Leili, ZHANG Linglin, LÜ Qian, YAN Jun, CUI Wei. Application of serum peptidomics based on MALDI-TOF MS in the differential diagnosis of benign and malignant pancreatic diseases [J]. Laboratory Medicine, 2023, 38(1): 1-7. |
[8] | ZHANG Meng, LI Sha, CHANG Yanli, WANG Lu, XU Jianjun, ZHANG Qingyun. Role of vascular endothelial growth factor in monitoring treatment outcome and evaluating the prognosis of patients with advanced melanoma [J]. Laboratory Medicine, 2022, 37(9): 821-825. |
[9] | Danhong , FANG Huiling, LIN Feiran, ZHU Yuqing. Comparison of testing efficiency of simulated emergency biochemical samples among different instruments GE [J]. Laboratory Medicine, 2022, 37(8): 766-771. |
[10] | TANG Ningbo, LIU Guancai, LIU Xiaoyu, YANG Fengfan, GONG Zhimei, SUN Keqi. Establishment and evaluation for the determination of serum digitoxin as a candidate reference method [J]. Laboratory Medicine, 2022, 37(5): 456-462. |
[11] | HAN Guang, XU Qiongfeng, DUAN Shumin, LUO Jiahuan, WANG Yunxiu, ZHANG Xiujuan, WAN Zemin, KE Peifeng, HUANG Xianzhang. Evaluation of the interference of serum index in the determination of prealbumin by immunoscattering turbidimetry according to CLSI EP07-A3 document [J]. Laboratory Medicine, 2022, 37(2): 108-111. |
[12] | LU Youli, YANG Shuangshuang, ZHANG Meiwei, OU Meixian, DONG Chunxia, SHEN Weiwei, JIANG Fengli, LI Shuijun. Simultaneous determination of 5 steroid hormones in human serum by ultra-performance liquid chromatography-tandem mass spectrometry and establishment of reference intervals in healthy adults [J]. Laboratory Medicine, 2022, 37(2): 165-173. |
[13] | XU Runhao, ZOU Chen, CAO Yun, CHEN Feng, LIU Yijing, ZHANG Shulin, ZHANG Jie. Roles of serum amino acid determinations in the diagnosis of early non-small-cell lung cancer [J]. Laboratory Medicine, 2022, 37(12): 1157-1163. |
[14] | XIONG Zhongbo, WANG Lei, YIN Beiqi, DAI Yue, WEI Xiaoqing, LU Pei. Clinical roles of SAA and CRP in pathological staging and metastasis of gastrointestinal cancer [J]. Laboratory Medicine, 2022, 37(1): 51-55. |
[15] | SUN Jingfang, LIU Yun, JIANG Qingqing, SONG Shuang, LI Shibao, MA Ping, DING Shuang. Clinical role of high-fluorescent cell and serum ascites albumin gradient in the diagnosis of malignant ascites [J]. Laboratory Medicine, 2022, 37(1): 60-62. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||